Vedolizumab as Induction and Maintenance Therapy for Ulcerative ColitisBrian G. Feagan, Asit Parikh, Jeffrey Axler et al.|New England Journal of Medicine|2013Cited by 2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's DiseaseWilliam J. Sandborn, Asit Parikh, Brian G. Feagan et al.|New England Journal of Medicine|2013Cited by 2.7k
The safety of vedolizumab for ulcerative colitis and Crohn's diseaseJean‐Frédéric Colombel, Brian G. Feagan, Bruce E. Sands et al.|Gut|2016Cited by 810
Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging StudyAsit Parikh, Brian G. Feagan, Timothy Leach et al.|Inflammatory Bowel Diseases|2011Cited by 211
Exposure–efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s DiseaseMaria Rosario, Irving H. Fox, Jonathan French et al.|Journal of Crohn s and Colitis|2017Cited by 161